On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents

Biomaterials

Volumn 28, Issue 6, 2007, Pages 895-908

  Jeremy, Jamie Y ^a   Gadsdon, Pat ^a   Shukla, Nilima ^a   Vijayan, Vikram ^a   Wyatt, Marcella ^a   Newby, Andrew C ^a   Angelini, Gianni D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Dacron stent; Saphenous vein graft failure; Vicryl sheath

Indexed keywords

BIOMATERIALS; DISEASE CONTROL; GENES; MEDICAL APPLICATIONS; SURGERY;

DACRON STENT; SAPHENOUS VEIN GRAFT FAILURE; VICRYL SHEATH;

GRAFTS;

BIOMATERIAL; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; PADGEM PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY INTIMA PROLIFERATION; ARTICLE; BIOLOGICAL MODEL; CYTOKINE PRODUCTION; DACRON IMPLANT; GRAFT FAILURE; HEMODYNAMICS; INFLAMMATORY CELL; OXIDATIVE STRESS; POROSITY; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE FIBER; STENT; SURGICAL RISK; SWINE; THICKNESS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VEIN INJURY;

ANIMALS; BIOLOGY; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; GRAFT REJECTION; GRAFT SURVIVAL; SAPHENOUS VEIN; STENTS; SWINE;

SUS SCROFA;

EID: 33751307254     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.10.023     Document Type: Article

References (93)

1. Favaloro R. Critical analysis of coronary artery bypass graft surgery: a 30 year journey. JACC 31 (1998) 1B-63B
2. Mortwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition and prevention. Circulation 97 (1998) 916-931
3. Fitzgibbon G.M., Kafka H.P., Leach A.J., Keon W.J., Hooper G.D., and Burton J.R. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 28 (1999) 616-626
4. Jackson M.R., Belott T.P., Dickason T., Kaiser W.J., Modrall J.G., Valentine R.J., et al. The consequences of a failed femoropopliteal bypass grafting: comparison of a saphenous vein and PTFE graft. J Vasc Surg 32 (2000) 498-505
5. Davies M.G., and Hagen P.-O. Pathobiology of intimal hyperplasia. Br J Surg 81 (1995) 1254-1269
6. Neitzel G.F., Barboriak J.J., Pintar K., et al. Atherosclerosis in aortocoronary bypass grafts. Morphological study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis 6 (1986) 594-600
7. Schwartz S.M., deBlois D., and O'Brien E.R.M. The neointima: soil for atherosclerosis and restenosis. Circ Res 77 (1996) 445-465
8. Campeau L. Lipid lowering and coronary bypass graft surgery. Curr Opin Cardiol 15 (2000) 395-399
9. Jeremy J.Y., Bryan A.J., and Angelini G.D. Pathophysiology and treatment of vein graft failure. J Drug Dev 7 (1996) 309-313
10. Jeremy J.Y., Jackson C.L., and Bryan A.J. Eicosanoids, fatty acids and restenosis following coronary artery bypass graft surgery and balloon angioplasty. Prostag Leukot Essent Fatty Acids 54 (1996) 385-402
11. Thatte H.S., and Khuri S.F. The coronary artery bypass conduit: Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg 72 (2001) S2245-S2252
12. Dobrin P.B., Golan J., and Fareed J. Pre- vs. postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein grafts. J Cardiovasc Surg 33 (1992) 705-709
13. Lerner R.G., Moggio R.A., and Reed G.E. Endothelial loss due to leukocytes in canine experimental vein-to-artery grafts. Blood Vessels 23 (1986) 173-182
14. Cooper J.P., and Newby A.C. Monocyte adhesion to human saphenous vein in vitro. Atherosclerosis 91 (1991) 85-95
15. Eslami M.H., Gangadharan S.P., Belkin M., et al. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?. J Vasc Surg 34 (2001) 923-929
16. Hernandez R., Alemany M., Bozzo J., et al. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate. Haemostasis 23 (1993) 1-7
17. Jeremy J.Y., Mehta D., Bryan A.J., and Angelini G.D. Platelets and saphenous vein graft failure. Platelets 8 (1997) 295-309
18. Cirillo P., Golino P., Ragni M., et al. Activated platelets and leucocytes co-operatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. Cardiovasc Res 43 (1999) 210-218
19. Golino P., Ambrosio G., Ragni M., et al. Inhibition of leucocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury. Thromb Haemost 77 (1997) 783-788
20. Schwarcz T.H., and Dobrin P.B. Role of platelets in the formation of intimal hyperplasia. Circ Res 77 (1995) 445-463
21. Bienvenu J.G., Tanguay J.F., Chauvet P., et al. Relationship between platelets and neutrophil adhesion and neointimal growth after repeated arterial wall injury induced by angioplasty in pigs. J Vasc Res 38 (2001) 153-162
22. Miller A.M., McPhaden A.R., and Wadsworth R.M. Inhibition by leukocyte depletion of neointima formation after balloon angioplasty in a rabbit model of restenosis. Cardiovasc Res 49 (2001) 838-850
23. Hoch J.R., Stark V.K., and Hullett D.A. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 116 (1994) 463-470
24. Hoch J.R., Stark V.K., and Turnipseed W.D. The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression. J Vasc Surg 22 (1995) 51-58
25. Gryglewski R.J., and Chlopicki S.J. Prostacyclin, nitric oxide and atherosclerosis. Ann NY Acad Sci USA 748 (1995) 194-207
26. Wu K.K., and Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 47 (1996) 315-331
27. Jeremy J.Y., Rowe D., Emsley A.M., and Newby A.C. Nitric oxide and vascular smooth muscle cell proliferation. Cardiovasc Res 43 (1999) 658-665
28. Jeremy J.Y., Birkett S., Bryan A.J., and Angelini G.D. Cyclic nucleotide synthesis by freshly isolated and surgically prepared human saphenous vein before and after 14 days culture. Eur J Vasc Endovasc Surg 13 (1997) 72-78
29. Jeremy J.Y., Shukla N., Muzaffar S., and Angelin G.D. Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol 2 (2004) 229-236
30. Jeremy J.Y., Yim A.P., Wan S., and Angelini G.D. Oxidative stress, nitric oxide and vascular disease. Cardiovasc Surg 17 (2002) 324-327
31. Jeremy J.Y., Dashwood M., Timm M., Izzat M., and Angelini G. Nitric oxide synthase and cyclic nucleotide synthesis by porcine venous-arterial grafts. Ann Thorac Surg 63 (1997) 470-476
32. Jeremy J.Y., Dashwood M., Mehta D., Izzat M.B., Bryan A.J., and Angelini G.D. Nitric oxide synthase, prostacyclin and cyclic nucleotide production in externally stented porcine vein grafts. Atherosclerosis 141 (1998) 297-305
33. Ehsan A., Mann M.J., Dell'Acqua G., et al. Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation 105 (2002) 1686-1692
34. Ku D.D., Caulfield J.B., and Kirklin J.K. Endothelium-dependent responses in long-term human coronary artery bypass grafts. Circulation 83 (1991) 402-411
35. Davies M.G., Klyachkin M.L., Svendsen E., et al. A comparative study of endothelium-derived relaxing factor-mediated relaxation and smooth muscle cell function in arterial and venous vein bypass grafts. Cardiovasc Surg 4 (1996) 150-160
36. Shimokawa H., Aarhus L.L., and Vanhoutte P.M. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res 61 (1987) 256-270
37. Powell J.T., and Gosling M. Molecular and cellular changes in vein grafts: influence of pulsatile stretch. Curr Opin Cardiol 13 (1998) 453-458
38. Ohno N., Itoh H., Ikeda T., et al. Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation 105 (2002) 1623-1626
39. Aplin A.E., Howe A., Alahari S.K., et al. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 50 (1998) 197-263
40. Stark V.K., Hoch J.R., and Warner T.F. Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. Arterioscler Thromb Vasc Biol 17 (1997) 1614-1621
41. Zou Y., Hu Y., Mayr M., et al. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res 86 (2000) 434-440
42. Crook M.F., Newby A.C., and Southgate K.M. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture. Atherosclerosis 150 (2000) 33-41
43. Chester A.H., Morrison K.J., and Yacoub M.H. Expression of vascular adhesion molecules in saphenous vein coronary artery bypass grafts. Ann Thorac Surg 65 (1998) 1685-1689
44. Alrawi S.J., Samee M., Raju R., et al. Intercellular and vascular cell adhesion molecule levels in endoscopic and open saphenous vein harvesting for coronary artery bypass graft surgery. Heart Surg Forum 3 (2000) 241-245
45. Walpola P.L., Gotlieb A.I., Cybulsky M.I., et al. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol 15 (1995) 2-10
46. Walpola P.L., Gotlieb A.I., and Langille B.L. Monocyte adhesion and changes in endothelial cell number, morphology, and F-actin distribution elicited by low shear stress in vivo. Am J Pathol 142 (1993) 1392-1400
47. Van der Wal A.C., Becker A.E., and Elbers J.R. An immunocytochemical analysis of rapidly progressive atherosclerosis in human vein grafts. Eur J Cardiothorac Surg 6 (1992) 469-473
48. Hoch J.R., Stark V.K., and van Rooijen N. Macrophage depletion alters vein graft intimal hyperplasia. Surgery 126 (1999) 428-437
49. Dobrin P.B., Littoy F.N., and Endean E.D. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 105 (1989) 393-400
50. Gibbons G.H., and Dzau V. The emerging concept of vascular remodeling. N Engl J Med 330 (1994) 1431-1438
51. Berk B.C. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81 (2001) 999-1030
52. Kroll M.H., Hellums J.D., McIntire L.V., et al. Platelets and shear stress. Blood 88 (1996) 1525-1541
53. Kawano K., Yoshino H., Aoki N., et al. Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis. Clin Cardiol 25 (2002) 154-160
54. Turitto V.T., and Hall C.L. Mechanical factors affecting hemostasis and thrombosis. Thromb Res 92 (1998) S25-S31
55. Caro C., Jeremy J.Y., Watkins N., Bulbulia R., Angelini G.D., et al. Geometry of unstented and stented pig common carotid artery bypass grafts. J Biorheol 39 (2002) 507-512
56. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
57. Griendling K.K., and Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. Lab Clin Med 132 (1998) 9-15
58. Gadsdon P., Yim A., Wan S., et al. Nitrated tyrosine in porcine stented and unstented vein grafts. Atherosclerosis 151 (2000) 108 [TuP3]
59. Muzaffar S., Jeremy J.Y., Angelini G.D., Stuart-Smith K., and Shukla N. The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries. Thorax 58 (2003) 598-604
60. 2□ in cultured porcine pulmonary artery vascular smooth muscle cells. Br J Pharmacol 141 (2004) 488-496
61. Muzaffar S., Shukla N., Angelini G.D., and Jeremy J.Y. Nitroaspirins and SIN-1, but not aspirin, inhibit the expression of endotoxin- and cytokine-induced NAPDH oxidase in vascular smooth muscle cells from pig pulmonary arteries. Circulation 110 (2004) 1140-1147
62. Dashwood M.R., Anand R., Loesch A., and Souza D.S. Hypothesis: a potential role for the vasa vasorum in the maintenance of vein graft patency. Angiology 55 (2004) 385-395
63. Barker S.G., Talbert A., Cottam S., et al. Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler Thromb 13 (1993) 70-77
64. Martin J.F., Booth R.F.G., and Moncada S. Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosis. Eur J Clin Invest 21 (1991) 355-359
65. Batson R.C., and Sottiurai V.S. Non-reversed and in situ vein grafts: clinical and experimental observations. Ann Surg 201 (1985) 770-779
66. McGeachie J.K., Campbell P.A., and Predergast F.J. Vein to artery grafts: a quantitative study of revascularisation by vasa vasorum and its relationship to intimal hyperplasia. Ann Surg 194 (1981) 100-107
67. Muzaffar S., Shukla N., Angelini G.D., and Jeremy J.Y. Hypoxia and the expression of gp91phox and endothelial nitric oxide synthase in the pulmonary artery. Thorax 60 (2005) 305-313
68. Jeremy J.Y., and Dashwood M.R. Microvascular repair. In: Shepro A.M. (Ed). Encyclopaedia of the microvasculature (2006), Elsevier Science 903-911
69. Parsonnet V.A.A., Lari A.A., and Shah I.H. New stent for support of veins in arterial grafts. Arch Surg 87 (1963) 696-702
70. Karayannacos P.E., Hostetler J.R., Bond M.G., Kakos G.S., Williams R.A., Kilman J.W., et al. Late failure in vein grafts: mediating factors in subendothelial fibromuscular hyperplasia. Ann Surg 187 (1978) 83-88
71. Angelini G.D., et al. External stenting reduces early medial and neointimal thickening in a pig model of arteriovenous bypass grafting. J Thorac Cardiovasc Surg 112 (1996) 79-84
72. Izzat M.B., Mehta D., Bryan A.J., Reeves B., Newby A.C., and Angeilin G.D. The influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation 94 (1996) 1741-1745
73. Mehta D., George S.J., Jeremy J.Y., Izzat M.B., Southgate K.M., Bryan A.J., et al. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med 4 (1998) 235-239
74. Violaris A., Newby A.C., and Angelini G.D. Effects of external stenting on wall thickening in arteriovenous bypass grafts. Ann Thorac Surg 55 (1993) 667-671
75. Vijayan V., Smith F.C., Angelini G.D., Bulbulia R.A., and Jeremy J.Y. External supports and the prevention of neointima formation in vein grafts. Eur J Vasc Endovasc Surg 24 (2002) 13-22
76. Bunt T.J. Synthetic vascular graft infections I. Graft infections. Surgery 93 (1983) 733-746
77. Edwards Jr. W.H., Martin III R.S., Jenkins J.M., Edwards Sr. W.H., and Mulherin Jr. J.L. Primary graft infections. J Vasc Surg 6 (1987) 235-239
78. Murphy G.J., Pararajasingam R., Nasim A., Dennis M.J., and Sayers R.D. Methicillin-resistant staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl 83 (2001) 158-163
79. Jeremy J.Y., Bulbulia R., Vijayan V., Johnson J.L., Gadsdon P., and Angelini G.D. A bioabsorbable (polyglactin) external sheath inhibits porcine saphenous vein graft thickening. J Thorac Cardiovasc Surg 127 (2004) 1766-1772
80. Vijayan V., Shukla N., Smith F.C.T., Angelini G.D., and Jeremy J.Y. A polyglactin biodegradable external stent prevents medial and intimal thickening but promotes marked neo vasa vasorum formation in porcine saphenous vein grafts in both the short and long term. J Vasc Surg 40 (2004) 1011-1019
81. Jacobson L.E., Kirton O.C., and Gomez G.A. The use of an absorbable mesh wrap in the management of major liver injuries. Surgery 111 (1992) 455-461
82. Lee S.S., Cheng C.L., Yu D.S., Chang S.Y., and Ma C.P. Vicryl mesh for repair of severely injured kidneys: an experimental study. J Trauma 34 (1993) 406-410
83. Tribble C.G., Joob A.W., Barone G.W., and Rodgers B.M. A new technique for wrapping the injured spleen with polyglactin mesh. Am Surg 53 (1987) 661-663
84. Dasdia T., Bazzaco S., Bottero L., Buffa R., Ferrero S., Campanelli G., et al. Organ culture in 3-dimensional matrix: in vitro model for evaluating biological compliance of synthetic meshes for abdominal wall repair. J Biomed Mater Res 43 (1998) 204-209
85. Paterson-Brown S., Cheslyn-Curtis S., Biglin J., Dye J., Easmon C.S., and Dudley H.A. Suture materials in contaminated wounds: a detailed comparison of a new suture with those currently in use. Br J Surg 74 (1987) 734-735
86. Demirer S., Gecim I.E., Aydinuraz K., Ataoglu H., Yerdel M.A., and Kuterdem E. Affinity of Staphylococcus epidermidis to various prosthetic graft materials. J Surg Res 99 (2001) 70-74
87. Franklin Jr. M.E., Gonzalez Jr. J.J., Michaelson R.P., Glass J.L., Chock D.A., et al. Preliminary experience with new bioactive prosthetic material for repair of hernias in infected fields. Hernia 6 (2002) 171-174
88. Greisler H.P., Endean E.D., Klosak J.J., Ellinger J., Dennis J.W., et al. Polyglactin 910/polydioxanone biocomponent totally resorbable vascular prostheses. J Vasc Surg 7 (1988) 697-705
89. George S.J., Izzat M.B., Gadsdon P., Johnson J.L., Yim A.P., Wan S., et al. Macro-porosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis 155 2 (2001) 329-336
90. Rosch R., Junge K., Schachtrupp A., Klinge U., Klosterhalfen B., and Schumpelick V. Mesh implants in hernia repair: inflammatory cell response in a rat model. Eur Surg Res 35 (2003) 161-166
91. Klinge U., Klosterhalfen B., Muller M., and Schumpelick V. Foreign body reaction to meshes used for the repair of abdominal wall hernias. Eur J Surg 165 (1999) 665-673
92. Goronzy J.J., and Weyand C.M. Cytokines in giant-cell arteritis. Clev Clin J Med 69 Suppl. 2 (2002) 91-94
93. van Amerongen M.J., Molema G., Plantinga J., Moorlag H., and van Luyn M.J. Neovascularization and vascular markers in a foreign body reaction to subcutaneously implanted degradable biomaterial in mice. Angiogenesis 5 (2002) 173-180